NCT/Study#

ASTX727-07

This is a single-arm, open-label, multicenter, non- randomized interventional study to evaluate the pharmacokinetic (PK) interaction, safety, and preliminary efficacy of ASTX727 when given in combination with venetoclax for the treatment of ACTIVEly diagnosed acute myeloid leukemia (AML) in adults who are age 75 years or older, or who have comorbidities that preclude use of intensive induction chemotherapy.

This is a single-arm, open-label, multicenter, non-
randomized interventional study to evaluate the pharmacokinetic (PK) interaction, safety, and preliminary efficacy of ASTX727
when given in combination with venetoclax for the treatment of ACTIVEly diagnosed acute myeloid leukemia (AML) in adults who
are age 75 years or older, or who have comorbidities that preclude use of intensive induction chemotherapy.

DISEASE GROUP:
Leukemia
current phase:
Phase II
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information: